Inhaled Carbon Monoxide Prevents Graft-Induced Intimal Hyperplasia in Swine

Journal of Surgical Research

Volumn 138, Issue 1, 2007, Pages 121-127

  Ramlawi, Basel ^a   Scott, Jeffrey R ^a   Feng, Jun ^a   Mieno, Shigetoshi ^a   Raman, Kathleen G ^b   Gallo, David ^a   Csizmadia, Eva ^a   Yoke Chin, Beek ^a   Bach, Fritz H ^a   Otterbein, Leo E ^a   Sellke, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

anastomosis; arteriovenous grafts; carbon monoxide; heme oxygenase 1; intimal hyperplasia; vascular smooth muscle proliferation

Indexed keywords

CARBON MONOXIDE; HEME; HEME OXYGENASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; BREATHING RATE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; END TO SIDE ANASTOMOSIS; FEMORAL ARTERY; FEMORAL VEIN; HEMODYNAMICS; INGUINAL REGION; INTRAOPERATIVE PERIOD; MALE; NONHUMAN; OXYGEN SATURATION; POLITEF IMPLANT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE; VEIN GRAFT;

ADMINISTRATION, INHALATION; ANIMALS; ANTIMETABOLITES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARBON MONOXIDE; CELL DIVISION; CELLS, CULTURED; FEMORAL ARTERY; FEMORAL VEIN; GRAFT OCCLUSION, VASCULAR; MALE; MUSCLE, SMOOTH, VASCULAR; POLYTETRAFLUOROETHYLENE; SUS SCROFA; TUNICA INTIMA;

EID: 33846867032     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.08.031     Document Type: Article

References (37)

1. Gibbons G.H., and Dzau V.J. The emerging concept of vascular remodeling. N Engl J Med 330 (1994) 1431
2. Otterbein L.E., Zuckerbraun B.S., Haga M., et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9 (2003) 183
3. Otterbein L.E., Soares M.P., Yamashita K., et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24 (2003) 449
4. Peyton K.J., Reyna S.V., Chapman G.B., et al. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99 (2002) 4443
5. Wagner C.T., Durante W., Christodoulides N., et al. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 100 (1997) 589
6. Chauveau C., Bouchet D., Roussel J.C., et al. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2 (2002) 581
7. Brouard S., Otterbein L.E., Anrather J., et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192 (2000) 1015
8. Duckers H.J., Boehm M., True A.L., et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7 (2001) 693
9. Liu X.M., Chapman G.B., Peyton K.J., et al. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 55 (2002) 396
10. Stanford S.J., Walters M.J., Hislop A.A., et al. Heme oxygenase is expressed in human pulmonary artery smooth muscle where carbon monoxide has an anti-proliferative role. Eur J Pharmacol 473 (2003) 135
11. Cardell L.O., Lou Y.P., Takeyama K., et al. Carbon monoxide, a cyclic GMP-related messenger, involved in hypoxic bronchodilation in vivo. Pulm Pharmacol Ther 11 (1998) 309
12. Brune B., and Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32 (1987) 497
13. Cardell L.O., Ueki I.F., Stjarne P., et al. Bronchodilatation in vivo by carbon monoxide, a cyclic GMP related messenger. Br J Pharmacol 124 (1998) 1065
14. Fujita T., Toda K., Karimova A., et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by depression of fibrinolysis. Nat Med 7 (2001) 598
15. Morita T., Mitsialis S.A., Koike H., et al. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272 (1997) 32804
16. Morita T., Perrella M.A., Lee M.E., et al. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92 (1995) 1475
17. Utz J., and Ullrich V. Carbon monoxide relaxes ileal smooth muscle through activation of guanylate cyclase. Biochem Pharmacol 41 (1991) 1195
18. Weaver L.K. Carbon monoxide poisoning. Crit Care Clin 15 (1999) 297 viii.
19. Ryter S.W., and Otterbein L.E. Carbon monoxide in biology and medicine. Bioessays 26 (2004) 270
20. Ryter S.W., Otterbein L.E., Morse D., et al. Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234 (2002) 249
21. Akamatsu Y., Haga M., Tyagi S., et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 18 (2004) 771
22. Motterlini R., Gonzales A., Foresti R., et al. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83 (1998) 568
23. Otterbein L.E., Bach F.H., Alam J., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 (2000) 422
24. Koyamada N., Miyatake T., Candinas D., et al. Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts. Transplantation 65 (1998) 1210
25. Sato K., Balla J., Otterbein L., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166 (2001) 4185
26. Soares M.P., Brouard S., Smith R.N., et al. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 184 (2001) 275
27. Soares M.P., Lin Y., Anrather J., et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4 (1998) 1073
28. Soares M.P., Lin Y., Sato K., et al. Accommodation. Immunol Today 20 (1999) 434
29. Ollinger R., Bilban M., Erat A., et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112 (2005) 1030
30. Naughton P., Foresti R., Bains S.K., et al. Induction of heme oxygenase 1 by nitrosative stress. A role for nitroxyl anion. J Biol Chem 277 (2002) 40666
31. Naughton P., Hoque M., Green C.J., et al. Interaction of heme with nitroxyl or nitric oxide amplifies heme oxygenase-1 induction: involvement of the transcription factor Nrf2. Cell Mol Biol (Noisy-le-grand) 48 (2002) 885
32. Kibbe M.R., Li J., Nie S., et al. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg 31 (2000) 1214
33. Kim Y.M., Bergonia H.A., Muller C., et al. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem 270 (1995) 5710
34. Exner M., Schillinger M., Minar E., et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 8 (2001) 433
35. Schillinger M., Exner M., Minar E., et al. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 43 (2004) 950
36. Yachie A., Niida Y., Wada T., et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103 (1999) 129
37. Lavitrano M., Smolenski R.T., Musumeci A., et al. Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J 18 (2004) 1093